Sector: MedicalIGXT (OTCBB: IGXT)
Headlines
- IntelGenx Achieves Positive Bioequivalence Results With Novel Anti-Migraine Film
Nov 17, 2009 06:01 AM | IGXT
- IntelGenx Reports Results For the Third Quarter and Nine Months Ended September 30, 2009
Nov 10, 2009 06:02 AM | IGXT
- BioMed News Bytes: IntelGenx, Pressure BioSciences
Oct 14, 2009 01:47 PM | BVF, IGXT, PBIO
- IntelGenx Determines Exercise Price of Stock Options to IR Firm
Oct 06, 2009 06:01 AM | IGXT
- IntelGenx Strengthens Investor Relations Activities
Oct 01, 2009 06:01 AM | IGXT
- IntelGenx Technologies Corp. Completes Additional Private Placement
Sep 04, 2009 03:50 PM | IGXT
- IntelGenx Technologies Corp. Announces Shareholder Call
Aug 31, 2009 06:14 AM | IGXT
- FDA Extreme Trades: 16 Stocks Under $5
Jun 27, 2009 04:55 PM | ANPI, APPA, CTIC, DDSS, GSK, HEB
- Cannasat Therapeutics and IntelGenx Corp. Reach Key Milestone Cannasat to Commence Phase 1(b) Study of CAT 310, a Potential Treatment for Neuropathic Pain
Jan 28, 2009 12:00 PM | IGXT
- IntelGenx Corp. Comments on CPI-300 Patent Infringement Complaint
Aug 21, 2009 06:00 PM | IGXT
- IntelGenx Reports Results for the Second Quarter and Six Months Ended June 30, 2009
Aug 14, 2009 06:01 AM | IGXT
- IntelGenx Technologies Corp. Announces Closing of Private Placement
Jul 14, 2009 10:50 AM | IGXT
- IntelGenx Corp. Announces FDA Acceptance for Filing of NDA for CPI-300 Antidepressant
Jun 23, 2009 06:01 AM | IGXT
- IntelGenx Corp. and Circ Pharma to Commence Phase 1 Proof-of-Concept Study of CRES Pravastatin, a Novel Low Dose Formulation Containing Pravastatin for the Treatment of Hyperlipidemia
May 19, 2009 06:01 AM | IGXT
- IntelGenx Reports Results for the First Quarter of 2009
May 13, 2009 06:00 AM | IGXT
- Positive Bioequivalence Results for IntelGenx Developed Product
Apr 20, 2009 06:10 AM | IGXT
- IntelGenx Announces Appointment of New Director
Apr 15, 2009 12:24 PM | IGXT
- Cannasat and IntelGenx Announce Positive Phase 1(b) Results Improved Buccal Tablet Outperforms Oral Dronabinol
Apr 14, 2009 10:09 AM | IGXT
- IntelGenx Corp. and Cary Pharmaceuticals File NDA for CPI-300 Antidepressant
Apr 07, 2009 06:01 AM | IGXT
- Form 4 IntelGenx Technologies For: Nov 24 Filed by: Boudreau Bernard (10K)
Nov 27, 2009 02:33 PM
- Form 4 IntelGenx Technologies For: Nov 24 Filed by: Zerbe Horst G (10K)
Nov 27, 2009 02:32 PM
- Form 4 IntelGenx Technologies For: Nov 24 Filed by: Troup John Archibald (10K)
Nov 27, 2009 02:31 PM
- Form 4 IntelGenx Technologies For: Nov 24 Filed by: Simmons Paul Anthony (10K)
Nov 27, 2009 02:29 PM
- Form 4 COHEN JOEL CHARLES For: May 12 (10K)
Jul 02, 2009 09:21 PM
- Form 4 IntelGenx Technologies For: Jun 29 Filed by: Northern Rivers Capital Management Inc. (10K)
Jul 02, 2009 06:42 PM
- Form 4 IntelGenx Technologies For: Mar 31 Filed by: Northern Rivers Capital Management Inc. (10K)
Apr 02, 2009 06:31 PM
- Form 4 IntelGenx Technologies For: Feb 26 Filed by: Northern Rivers Capital Management Inc. (10K)
Mar 02, 2009 05:09 PM
- Form 3 IntelGenx Technologies For: Dec 31 Filed by: Northern Rivers Capital Management Inc. (10K)
Feb 13, 2009 05:49 PM
- Form 3 Troup John Archibald For: Sep 08 (10K)
Oct 22, 2008 07:40 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
IGXT
|
Compare to S&P
|
| YTD |
0.00 %
|
-17.24 %
|
| 4 Weeks |
-9.09 %
|
-10.07 %
|
| 12 Weeks |
11.11 %
|
4.75 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -100.00 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: -23.40 %
|
|
Sales Growth in Last Quarter: 40.81 %
|
|
